Why Attend?
Now in its 6th year, the Dermatology Drug Development Summit Europe continues to be the go-to meeting for biopharma leaders shaping the future of immunodermatology. As modalities diversify, targeted indications expand, and inflammatory pathways are increasingly elucidated, the need to differentiate your pipelines in an evolving landscape has never been greater.
This year, join 80+ senior leaders to:
- Explore cutting-edge therapeutic advancements
- Overcome clinical bottlenecks
- Refine strategies for market success
With insights from leaders across pharma, biotech, and academia, this is your chance to gain a competitive edge and accelerate the development of next-generation dermatology therapies.
What Will You Gain?
Who Will You Meet?
This summit is designed for senior leaders in R&D, Clinical Development, Medical Affairs, and Regulatory Affairs from biotech and pharma companies advancing immunodermatology pipelines. Whether you're refining clinical strategies, exploring novel targets, or overcoming development bottlenecks, this event delivers the critical insights and networking opportunities needed to drive your dermatology programs forward.
What Your Peers Have to Say
“Excellent networking with colleges who are really dedicated to dermatology drug development.” - Eurofins
“I enjoyed attending and speaking at Hanson Wade summit. It is a great way to network. I enjoy the round table discussions and exposure to various facets of drug discovery.” - Merck & Co
“The intimate and transparent atmosphere, the dedicated networking sessions, the relevance & quality of the presentations and the number of dermatology leaders attending were all great.” - Sanos Group
Previously Attending Companies Include:
